Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing chemotherapy and targeted therapy in liver hepatocellular carcinoma.
Article in Aging (May 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Aging (May 2024)
Article in Journal of Hepatocellular Carcinoma (September 2023)
Article in Journal of Cancer Research and Clinical Oncology (June 2023)